Barbara Torlinska

Medicine & Life Sciences

1. Hyperthyroidism 100%
2. SARS Virus 68%
3. Saliva 45%
4. Patient Reported Outcome Measures 42%
5. Antibody Formation 42%
6. Glycoproteins 39%
7. Oxandrolone 39%
8. Longitudinal Studies 38%
9. Hypothyroidism 37%
10. Cohort Studies 35%
11. Immunoglobulin G 32%
12. Secondary Care 32%
13. Mortality 30%
14. Quality of Life 30%
15. Health Policy 26%
16. Iodine 26%
17. Highly Active Antiretroviral Therapy 26%
18. Thyroid Diseases 26%
19. Antibodies 25%
20. Immunoglobulin A 25%
21. Thyrotropin 24%
22. Pandemics 24%
23. Arthralgia 24%
24. Eye Diseases 24%
25. Immunoglobulin M 24%
26. Wounds and Injuries 22%
27. Intubation 22%
28. Serum 22%
29. Weights and Measures 22%
30. Inhalation 21%
31. Transplant Recipients 21%
32. Uncertainty 21%
33. Obstetrics 21%
34. Thyroid Gland 20%
35. Arthritis 20%
36. Signs and Symptoms 20%
37. Fatigue 19%
38. Rheumatoid Arthritis 19%
39. Enzyme-Linked Immunosorbent Assay 19%
40. Therapeutics 19%
41. Cross-Sectional Studies 18%
42. Parents 17%
43. Steroids 17%
44. Retrospective Studies 17%
45. Systematic Reviews 17%
46. Infections 17%
47. Nucleocapsid 16%
48. Antigens 16%
49. HIV 16%
50. Delivery of Health Care 15%